Are animal models predictive for humans?
Open accessThe DOI matches its Crossref record; 77 of the 79 references it cites were found in a registry or an index.
Abstract
It is one of the central aims of the philosophy of science to elucidate the meanings of scientific terms and also to think critically about their application. The focus of this essay is the scientific term predict and whether there is credible evidence that animal models, especially in toxicology and pathophysiology, can be used to predict human outcomes. Whether animals can be used to predict human response to drugs and other chemicals is apparently a contentious issue. However, when one empirically analyzes animal models using scientific tools they fall far short of being able to predict human responses. This is not surprising considering what we have learned from fields such evolutionary and developmental biology, gene regulation and expression, epigenetics, complexity theory, and comparative genomics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“first because referencing practices are suboptimal (compare e.g. the data and figures from [5, 72, 73, 77].”
From Animal to human translation: a systematic scoping review of reported concordance rates (2019) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Traditional two-dimensional cell cultures and in vivo animal studies fail to fully recapitulate human cardiac physiology, highlighting the urgent need for more relevant human-based models.”
From Mini-hearts for disease modeling and drug testing – process optimization versus biological functionality (2026) · cites this paper as Shanks et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Regulatory and research leaders are increasingly taking notice of the issue.”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [62]
The cited source says what the claim attributes to it.
In the citing paper
“Even if the design and conduct of an animal experiment are sound and standardized, the translation of its results to the clinic may fail because of disparities between the animal experimental model and the human condition.21”
From The Flaws and Human Harms of Animal Experimentation (2015) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602 · cited 1×
“The response of different humans to the same drug or disease is a well-known example of this phenomenon [7-13].”
Bleyl, D. W. R. (1989) · Food / Nahrung · doi:10.1002/food.19890330516 · Cited by 2,305
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 2×
“The Olson study [78] purports (and has certainly been cited in this regard) to provide evidence of the vast predictive utility of animal models in assessing human toxicity.”
IARC monographs on the evaluation of carcinogenic risks to humans
(1989) · Food and Chemical Toxicology · doi:10.1016/0278-6915(89)90053-7 · Cited by 1,447
Casarett and Doull's toxicology
ed, T. (2015) · Cited by 1,127
Modelling the molecular circuitry of cancer
Hahn, W. C., & Weinberg, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc795 · Cited by 944 · cited 1×
“It also appears that fewer genetic, epigenetic, or gene expression events are needed to induce cancer in rodents than are needed to induce cancer in humans [72-74].”
Bruder, C. E. G., Piotrowski, A., Gijsbers, A. A. C. J., Andersson, R., Erickson, S., Diaz de Ståhl, T., Menzel, U., Sandgren, J., von Tell, D., Poplawski, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.011 · Cited by 599 · cited 1×
“The response of different humans to the same drug or disease is a wellknown example of this phenomenon [7-13].”
Failing the Public Health — Rofecoxib, Merck, and the FDA
Topol, E. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048286 · Cited by 599 · cited 1×
“Figures vary, and are controversial, but it now appears that apparently less than 1% of people who took rofecoxib experienced a heart attack or stroke as a result, yet it was also withdrawn [35].”
Comparative biology of mouse versus human cells: modelling human cancer in mice
Rangarajan, A., & Weinberg, R. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1235 · Cited by 567 · cited 1×
“It also appears that fewer genetic, epigenetic, or gene expression events are needed to induce cancer in rodents than are needed to induce cancer in humans [72-74].”
Research works printed but not linked: 14
- Greek R Greek J Specious Science 2002 New York: Continuum Int
- Salmon W Curd M, Cover J, Norton Rational Prediction Philosophy of Science 1998 433 444
- Uehling M Microdoses of Excitement over AMS, 'Phase 0' Trials Bio-IT World 2006 2006
- Greek J Greek R What Will We Do if We Don't Experiment on Animals. Continuum 2004
- Sankar U The Delicate Toxicity Balance in Drug Discovery The Scientist 2005 19 32
- Tomatis L Wilbourn L Iversen Evaluation of carcinogenic risk to humans: the experience of IARC New Frontiers in Cancer Causation 2003 Washington, DC: Taylor and Francis 371 387
- Caldwell J Jakoby W Comparative Aspects of Detoxification in Mammals Enzymatic Basis of Detoxification 1980 1 New York: Academic Press
- Clemmensen J Hjalgrim-Jensen S Alex Pub On the absence of carcinogenicity to man of phenobarbital Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis 1980 Coulston F, Shubick S 251 265
- Clayson D Coulston F, Shubick P The carcinogenic action of drugs in man and animals Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis 1980 Ablex Pub 185 195
- Anisimov V Molecular and Physiological Mechanisms of Aging 2003 St Petersburg: Nauka
- Kolata G 2 Top Diet Drugs Are Recalled Amid Reports of Heart Defects New York Times. New York 1997
- Shanks N Greek R Nobis N Greek J Animals and Medicine: Do Animal Experiments Predict Human Response? Skeptic 2007 13 44 51
- Conn P Parker J Letter. Animal research wars Skeptic 2007 13 18 19
- Morange M A successful form for reductionism The Biochemist 2001 23 37 39
Cited by
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
“From a comparative therapeutics perspective, an argument can be made that body weight adjusted dosing of a cell drug in rodents may not precisely predict human pharmacology or response(Shanks et al., 2009).”
BackgroundAn in vivo model of functional and vascularized human brain organoids
Mansour, A. A., Gonçalves, J. T., Bloyd, C. W., Li, H., Fernandes, S., Quang, D., Johnston, S., Parylak, S. L., Jin, X., & Gage, F. H. (2018) · Nature Biotechnology · doi:10.1038/nbt.4127 · Cited by 1,211
“5 dpi (1) 5 dpi (2) 14 dpi 50 dpi 233 dpi O rg an oi d”
MethodNetwork pharmacology: curing causal mechanisms instead of treating symptoms
Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., & Schmidt, H. H. H. W. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.11.004 · Cited by 1,201
Progress in 3D bioprinting technology for tissue/organ regenerative engineering
Matai, I., Kaur, G., Seyedsalehi, A., McClinton, A., & Laurencin, C. T. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119536 · Cited by 1,156
Analysis of drug combinations: current methodological landscape
Foucquier, J., & Guedj, M. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.149 · Cited by 1,115
“The extrapolation of results from in vitro to animals, or from animals to humans is a general and separate scientific debate which is not expected to be solved here (Shanks et al. 2009; Chou 2010; Tsilidis et al. 2013; Hay et al. 2014).”
BackgroundEngineering Stem Cell Organoids
Yin, X., Mead, B. E., Safaee, H., Langer, R., Karp, J. M., & Levy, O. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.12.005 · Cited by 866
“A uthor M anuscript A uthor M anuscript throughput, limited usability, and differences between animal and human biology (Shanks et al., 2009).”
A comprehensive review on droplet-based bioprinting: Past, present and future
Gudapati, H., Dey, M., & Ozbolat, I. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.012 · Cited by 859
“echanics Department, Penn [1,12] can improve in-vitro drug testing by replacing twodimensional (2D) cell culture and animal models as animal models are not effective at predicting human toxicological and pathophysiological responses [13] and 2D culture models do not closely mimic complex 3D micro-tissue environment [1…”
BackgroundDevelopment of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids
Kasendra, M., Tovaglieri, A., Sontheimer-Phelps, A., Jalili-Firoozinezhad, S., Bein, A., Chalkiadaki, A., Scholl, W., Zhang, C., Rickner, H., Richmond, C. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21201-7 · Cited by 754
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
“Secretary of Health and Human Services, stated, “nine out of ten experimental drugs fail in clinical studies because we cannot accurately predict how they will behave in people based on laboratory and animal studies” (62,63).”
BackgroundAlternative (non-animal) methods for cosmetics testing: current status and future prospects—2010
Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K. E., Angers-Loustau, A., Aptula, A., Bal-Price, A., et al. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0693-2 · Cited by 584
“consequently, are not predictive for humans (Shanks et al. 2009).”
The Flaws and Human Harms of Animal Experimentation
AKHTAR, A. (2015) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180115000079 · Cited by 527
Herland, A., Maoz, B. M., Das, D., Somayaji, M. R., Prantil-Baun, R., Novak, R., Cronce, M., Huffstater, T., Jeanty, S. S. F., Ingram, M., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0498-9 · Cited by 500
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
“Although, in-vitro studies have suggested their pharmacological effectiveness, studies involving animal models and patients generally fail to achieve sufficient therapeutic activity [5,6].”
Power, M. C., Adar, S. D., Yanosky, J. D., & Weuve, J. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.004 · Cited by 422
Glioblastoma Model Using Human Cerebral Organoids
Ogawa, J., Pao, G. M., Shokhirev, M. N., & Verma, I. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.105 · Cited by 391
“This has been largely fueled by the fact that results derived from mouse genetic models of experimental therapeutics are not always useful predictors of outcomes in human clinical trials (Hackam and Redelmeier, 2006; Shanks et al., 2009; Van Der Worp et al., 2010).”
BackgroundDiscovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches
Papadimitriou, K., Zoumpopoulou, G., Foligné, B., Alexandraki, V., Kazou, M., Pot, B., & Tsakalidou, E. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00058 · Cited by 384
“Shanks et al. (2009) illustrate with numerous examples their importance,or lack thereof,in the different steps of the complete research process.”
BackgroundResultMicrofluidic organ-on-chip technology for blood-brain barrier research
van der Helm, M. W., van der Meer, A. D., Eijkel, J. C. T., van den Berg, A., & Segerink, L. I. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1142493 · Cited by 333
Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance
Erhirhie, E. O., Ihekwereme, C. P., & Ilodigwe, E. E. (2018) · Interdisciplinary Toxicology · doi:10.2478/intox-2018-0001 · Cited by 329
“Degeneration of cells due to continuous depletion of nutrients, accumulation of waste products, and insufficient oxygen supply resulting in anaerobic culture conditions are often common with some in vitro conditions (Shanks et al., 2009).”
BackgroundAnimal to human translation: a systematic scoping review of reported concordance rates
Leenaars, C. H. C., Kouwenaar, C., Stafleu, F. R., Bleich, A., Ritskes-Hoitinga, M., De Vries, R. B. M., & Meijboom, F. L. B. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1976-2 · Cited by 314
An Overview on Materials and Techniques in 3D Bioprinting Toward Biomedical Application
Vanaei, S., Parizi, M. S., Vanaei, S., Salemizadehparizi, F., & Vanaei, H. R. (2021) · Engineered Regeneration · doi:10.1016/j.engreg.2020.12.001 · Cited by 308
Discovery and development of safe-in-man broad-spectrum antiviral agents
Andersen, P. I., Ianevski, A., Lysvand, H., Vitkauskiene, A., Oksenych, V., Bjørås, M., Telling, K., Lutsar, I., Dumpis, U., Irie, Y., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.018 · Cited by 280
“Although animal models can give the initial characterization of BSAA, it is important to keep in mind that they differ significantly from humans, with respect to symptoms, disease manifestation, susceptibility, immune responses, pathogenesis, and pharmacokinetics (Barré-Sinoussi and Montagutelli, 2015; Shanks et al.,…”
Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do
Ribitsch, I., Baptista, P. M., Lange-Consiglio, A., Melotti, L., Patruno, M., Jenner, F., Schnabl-Feichter, E., Dutton, L. C., Connolly, D. J., van Steenbeek, F. G., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00972 · Cited by 249
“To date, animal models of human asthma have included: Drosophila, rats, guinea pigs, cats, dogs, pigs, cattle, sheep, horses and primates, but the most widely used model is the mouse (Zosky and Sly, 2007; Kirschvink and Reinhold, 2008; Shapiro, 2008; Blume and Davies, 2013).”
BackgroundMethodIn vitro approaches to assess the hazard of nanomaterials
Drasler, B., Sayre, P., Steinhäuser, K. G., Petri-Fink, A., & Rothen-Rutishauser, B. (2017) · NanoImpact · doi:10.1016/j.impact.2017.08.002 · Cited by 245
“Moreover, the outcomes of animal testing regarding its predictive power for human beings exhibit certain limitations, mainly due to physiological and biochemical species dissimilarities (Shanks et al., 2009).”
BackgroundGut-on-a-chip: Current progress and future opportunities
Ashammakhi, N., Nasiri, R., Barros, N. R. D., Tebon, P., Thakor, J., Goudie, M., Shamloo, A., Martin, M. G., & Khademhosseini, A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120196 · Cited by 235
The US Federal Tox21 Program: A strategic and operational plan for continued leadership
Thomas, R. (2018) · ALTEX · doi:10.14573/altex.1803011 · Cited by 229
Musunuru, K., Sheikh, F., Gupta, R. M., Houser, S. R., Maher, K. O., Milan, D. J., Terzic, A., & Wu, J. C. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000043 · Cited by 229
Impact of Diabetes Mellitus on Bone Health
Murray, C. E., & Coleman, C. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194873 · Cited by 228
A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing
Basketter, D. (2012) · ALTEX · doi:10.14573/altex.2012.1.003 · Cited by 225
“In addition, the assay’s predictivity for humans has been challenged (Knight et al., 2006a,b,c; Shanks et al., 2009).”
MethodPolymeric vehicles for nucleic acid delivery
Piotrowski-Daspit, A. S., Kauffman, A. C., Bracaglia, L. G., & Saltzman, W. M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.014 · Cited by 224
Current Developments in 3D Bioprinting for Tissue and Organ Regeneration–A Review
Agarwal, S., Saha, S., Balla, V. K., Pal, A., Barui, A., & Bodhak, S. (2020) · Frontiers in Mechanical Engineering · doi:10.3389/fmech.2020.589171 · Cited by 221
Streptozotocin as a tool for induction of rat models of diabetes: a practical guide
Ghasemi, A., & Jeddi, S. (2022) · EXCLI journal · doi:10.17179/excli2022-5720 · Cited by 208
“However, there is controversy concerning the predictive power of animal models (Shanks et al., 2009).”
BackgroundInfluentialSystematic reviews of animal models: methodology versus epistemology
Greek, R., & Menache, A. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5529 · Cited by 207
“(For more on the failure of animal models of human disease to correlate with humans, see [62, 64-66, 96-100].”
BackgroundSelf-citationAre In Vitro Tests Suitable for Regulatory Use?
Hartung, T., & Daston, G. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp149 · Cited by 202
“The inevitable killing of animals raises increasing ethical concerns (Hartung, 2008b; Matthews, 2008; Shanks et al., 2009).”
BackgroundComparison of DNA and mRNA vaccines against cancer
Jahanafrooz, Z., Baradaran, B., Mosafer, J., Hashemzaei, M., Rezaei, T., Mokhtarzadeh, A., & Hamblin, M. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2019.12.003 · Cited by 202
Molecular Networks of Human Muscle Adaptation to Exercise and Age
Phillips, B. E., Williams, J. P., Gustafsson, T., Bouchard, C., Rankinen, T., Knudsen, S., Smith, K., Timmons, J. A., & Atherton, P. J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003389 · Cited by 199
“Part of the reason for this is that the investment in forward genetic pre-clinical models [81] has not yielded the expected validation of drug targets and it is now widely accepted that the clinical approach to chronicdisease management will have to reflect on numerous interactions between environmental and molecular…”
BackgroundDietary oxidative stress and antioxidant defense with an emphasis on plant extract administration
Veskoukis, A. S., Tsatsakis, A. M., & Kouretas, D. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-011-0293-3 · Cited by 192
“main aims of the philosophy of science is the scientific term “predict” and whether it is realistic that animal models can be used to predict human outcomes (Shanks et al. 2009).”
Monticello, T. M., Jones, T. W., Dambach, D. M., Potter, D. M., Bolt, M. W., Liu, M., Keller, D. A., Hart, T. K., & Kadambi, V. J. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.09.006 · Cited by 186
“Furthermore, there has been debate regarding the value of animal models in both drug discovery and development (Shanks et al., 2009; van Meer et al., 2012; Bailey et al., 2013; Hartung, 2013; Greek and Menache, 2013; Mangipudy et al., 2014; Bailey et al., 2015).”
BackgroundWest, P. R., Weir, A. M., Smith, A. M., Donley, E. L. R., & Cezar, G. G. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.05.007 · Cited by 185
“Teratogens include a wide range of chemical substances for which currently available animal models have a limited ability to correlate toxicity outcomes to human response (Shanks et al., 2009).”
BackgroundSeal, S., Mahale, M., García-Ortegón, M., Joshi, C. K., Hosseini-Gerami, L., Beatson, A., Greenig, M., Shekhar, M., Patra, A., Weis, C., et al. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5c00033 · Cited by 185
Cao, X., Coyle, J. P., Xiong, R., Wang, Y., Heflich, R. H., Ren, B., Gwinn, W. M., Hayden, P. J., & Rojanasakul, L. W. (2020) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00517-7 · Cited by 176
Engineering 3D Hydrogels for Personalized In Vitro Human Tissue Models
Liaw, C., Ji, S., & Guvendiren, M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701165 · Cited by 170
Doherty, K. R., Wappel, R. L., Talbert, D. R., Trusk, P. B., Moran, D. M., Kramer, J. W., Brown, A. M., Shell, S. A., & Bacus, S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.027 · Cited by 170
Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
Akil, A. A.-S., Yassin, E., Al-Maraghi, A., Aliyev, E., Al-Malki, K., & Fakhro, K. A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02778-6 · Cited by 168
“Taken together, extreme caution must be exercised when attempting to draw conclusions from animal models and apply them to the human situation [219].”
BackgroundEffect of orthodontic treatment on the periodontal tissues
Antoun, J. S., Mei, L., Gibbs, K., & Farella, M. (2017) · Periodontology 2000 · doi:10.1111/prd.12194 · Cited by 166
A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans
Clark, M., & Steger-Hartmann, T. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.04.018 · Cited by 162
Canine mammary tumors as a model for human disease (Review)
Abdelmegeed, S., & Mohammed, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.8411 · Cited by 158
“Rats are easier to use in research than mice, as they are larger in size (52,53).”
In vitro biomimetic engineering of a human hematopoietic niche with functional properties
Bourgine, P. E., Klein, T., Paczulla, A. M., Shimizu, T., Kunz, L., Kokkaliaris, K. D., Coutu, D. L., Lengerke, C., Skoda, R., Schroeder, T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805440115 · Cited by 158
“Chimeric animal models (10) most closely recapitulate in vivo human physiology, but, in this setting, the niche has remained inaccessible to experimental manipulation and optical observation (11, 12).”
BackgroundDesign and Fabrication of Organ-on-Chips: Promises and Challenges
Tajeddin, A., & Mustafaoğlu, N. (2021) · Micromachines · doi:10.3390/mi12121443 · Cited by 160
Tsaioun, K. (2016) · ALTEX · doi:10.14573/altex.1610101 · Cited by 131
Quader, S., Kataoka, K., & Cabral, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114115 · Cited by 155
Louisse, J., Beekmann, K., & Rietjens, I. M. C. M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00302 · Cited by 154
Animal models as a tool in hepatocellular carcinoma research: A Review
Santos, N. P., Colaço, A. A., & Oliveira, P. A. (2017) · Tumor Biology · doi:10.1177/1010428317695923 · Cited by 151
3D Printed Neural Regeneration Devices
Joung, D., Lavoie, N., Guo, S., Park, S. H., Parr, A. M., & McAlpine, M. C. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201906237 · Cited by 153
Alexander-Dann, B., Pruteanu, L.-L., Oerton, E., Sharma, N., Berindan‐Neagoe, I., Módos, D., & Bender, A. (2018) · Molecular Omics · doi:10.1039/c8mo00042e · Cited by 149
Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development
Li, Z., Hui, J., Yang, P., & Mao, H. (2022) · Biosensors · doi:10.3390/bios12060370 · Cited by 120
“currently do not accurately predict how drugs will react in humans [12].”
BackgroundGutierrez, E. (2013) · International Journal of Eating Disorders · doi:10.1002/eat.22095 · Cited by 128
A critical perspective on 3D liver models for drug metabolism and toxicology studies
Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138
Safety data and withdrawal of hepatotoxic drugs
Babai, S., Auclert, L., & Le-Louët, H. (2018) · Therapies · doi:10.1016/j.therap.2018.02.004 · Cited by 137
Mouse Models as Predictors of Human Responses: Evolutionary Medicine
Uhl, E. W., & Warner, N. J. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0086-y · Cited by 113
Antidepressants- and antipsychotics-induced hepatotoxicity
Todorović Vukotić, N., Đorđević, J., Pejić, S., Đorđević, N., & Pajović, S. B. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02963-4 · Cited by 114
The comet assay in animal models: From bugs to whales – (Part 1 Invertebrates)
Gajski, G., Žegura, B., Ladeira, C., Pourrut, B., Bo’, C. D., Novak, M., Šrámková, M., Milić, M., Gützkow, K. B., Costa, S., et al. (2019) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2019.02.003 · Cited by 131
Osteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs
Lin, Z., Li, Z. A., Li, E. N., Li, X., Duke, C. D., Shen, H., Hao, T., O’Donnell, B. T., Bunnell, B. A., Goodman, S. B., et al. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00411 · Cited by 130
“Although animal models are often used in biomedical research (Rosenthal and Brown, 2007), the translation potential of these animal models to human conditions is often low (Shanks et al., 2009; Seok et al., 2013).”
BackgroundAdvances in 3D skin bioprinting for wound healing and disease modeling
Zhang, M., Zhang, C., Li, Z., Fu, X., & Huang, S. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac105 · Cited by 130
“Numerous instances of significant differences between the disease phenotypes observed in animal models and humans have been reported [76, 156, 157].”
Gut-on-chip: Recreating human intestine in vitro
Xiang, Y., Wen, H., Yu, Y., Li, M., Fu, X., & Huang, S. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420965318 · Cited by 127
Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine
Chen, X., Zhang, Y. S., Zhang, X., & Liu, C. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.09.022 · Cited by 107
Ahangari, F., Becker, C., Foster, D. G., Chioccioli, M., Nelson, M., Beke, K. M., Wang, X., Justet, A., Adams, T. S., Readhead, B. P., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3832oc · Cited by 124
Clinical Trials in Alzheimer’s Disease: A Hurdle in the Path of Remedy
Oxford, A. E., Stewart, E. S., & Rohn, T. T. (2020) · International Journal of Alzheimer's Disease · doi:10.1155/2020/5380346 · Cited by 107
“Though animal models provide undeniably important data in research, these studies are able to predict human toxicity correctly in only 70% of cases [97, 98].”
BackgroundUccelli, A., Laroni, A., Ali, R., Battaglia, M. A., Blinkenberg, M., Brundin, L., Clanet, M., Fernandez, O., Marriott, J., Muraro, P., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00301-x · Cited by 110
Animals and the Shaping of Modern Medicine
Woods, A., Bresalier, M., Cassidy, A., & Dentinger, R. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64337-3 · Cited by 122
3D and organoid culture in research: physiology, hereditary genetic diseases and cancer
Suarez-Martinez, E., Suazo-Sanchez, I., Celis-Romero, M., & Carnero, A. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00775-w · Cited by 118
“Thus, they can predict how a treatment or a disease may develop, although they are limited by the differences among species biology, the differences in sensitivity, the cost of maintenance and a limited throughput [1, 2].”
BackgroundCooke, S. J., Birnie‐Gauvin, K., Lennox, R. J., Taylor, J. J., Rytwinski, T., Rummer, J. L., Franklin, C. E., Bennett, J., & Haddaway, N. (2017) · Conservation Physiology · doi:10.1093/conphys/cox043 · Cited by 118
“Surrogates offer an avenue for experimentation to reduce the cost of some problems (e.g. animal models in medical science; Shanks et al. , 2009).”
BackgroundOrgan-on-a-chip engineering: Toward bridging the gap between lab and industry
Ramadan, Q., & Zourob, M. M. (2020) · Biomicrofluidics · doi:10.1063/5.0011583 · Cited by 113
Qu, S., Xu, R., Yi, G., Li, Z., Zhang, H., Qi, S., & Huang, G. (2024) · Molecular Biomedicine · doi:10.1186/s43556-023-00165-9 · Cited by 117
Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models
Bhattacharya, S., Calar, K., & de la Puente, P. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01583-1 · Cited by 99
Curzer, H. J., Perry, G., Wallace, M. C., & Perry, D. (2015) · Science and Engineering Ethics · doi:10.1007/s11948-015-9659-8 · Cited by 111
“Such claims are, of course, strongly denied by many researchers (see, e.g., review in Mukerjee 1997), but others agree that basic assumptions underlying the usefulness of some animal research remain poorly substantiated (e.g., Horrobin 2003; Greek and Greek 2010; Shanks et al. 2009).”
BackgroundSimulating Next-Generation Sequencing Datasets from Empirical Mutation and Sequencing Models
Stephens, Z. D., Hudson, M. E., Mainzer, L. S., Taschuk, M. L., Weber, M., & Iyer, R. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167047 · Cited by 109
Pavlićević, M., Maestri, E., & Marmiroli, M. (2020) · Marine Drugs · doi:10.3390/md18080424 · Cited by 109
Humanized Mice as Unique Tools for Human-Specific Studies
Yong, K. S. M., Her, Z., & Chen, Q. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0506-x · Cited by 97
“A major technical barrier in translating these discoveries to treatments is caused by differences in the biological systems between animals and humans (Greek and Rice 2012; Mestas and Hughes 2004; Shanks et al. 2009; Van der Worp et al. 2010).”
BackgroundEmerging from the bottleneck: benefits of the comparative approach to modern neuroscience
Brenowitz, E. A., & Zakon, H. H. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.02.008 · Cited by 109
“2 Shanks, N. et al. (2009) Are animal models predictive for humans? Philos. Ethics Humanit. Med. 4, 2 3 Carlson, B.A. (2012) Diversity matters: the importance of comparative studies and the potential for synergy between neuroscience and evolutionary biology. Arch. Neurol. 69, 987–993 4 Hale, M.E. (2014) Mapping circui…”
InfluentialBonilla, D. A., Moreno, Y., Gho, C., Petro, J. L., Odriozola-Martínez, A., & Kreider, R. B. (2021) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk6010020 · Cited by 106
“Even though animal and in vitro studies cannot be directly extrapolated to human effects and their results have to be interpreted with attention [49], several animal and cell studies have identified potential molecular targets of the secondary metabolites of this herbal extract that could be involved in the regulation…”
BackgroundRadiation dose rate effects: what is new and what is needed?
Lowe, D., Roy, L., Tabocchini, M. A., Rühm, W., Wakeford, R., Woloschak, G. E., & Laurier, D. (2022) · Radiation and Environmental Biophysics · doi:10.1007/s00411-022-00996-0 · Cited by 107
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
The application of 3D cell models to support drug safety assessment: Opportunities & challenges
Roth, A. B., & Singer, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.005 · Cited by 105
The current status of biomarkers for predicting toxicity
Campion, S., Aubrecht, J., Boekelheide, K., Brewster, D. W., Vaidya, V. S., Anderson, L., Burt, D., Dere, E., Hwang, K., Pacheco, S., et al. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.827170 · Cited by 97
“This conclusion has been debated over the past decade [3], since the only drugs studied were those in clinical studies, and by necessity those that failed in preclinical studies due to unacceptable toxicity were not evaluated in the clinical setting.”
BackgroundHuman vascular microphysiological system for in vitro drug screening
Fernandez, C. E., Yen, R. W., Perez, S. M., Bedell, H. W., Povsic, T. J., Reichert, W. M., & Truskey, G. A. (2016) · Scientific Reports · doi:10.1038/srep21579 · Cited by 93
Varone, A., Nguyen, J. K., Leng, L., Barrile, R., Sliz, J. D., Lucchesi, C., Wen, N., Gravanis, A., Hamilton, G. A., Karalis, K., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120957 · Cited by 94
Astaxanthin in Exercise Metabolism, Performance and Recovery: A Review
Brown, D., Gough, L. A., Deb, S. K., Sparks, S. A., & McNaughton, L. R. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00076 · Cited by 92
“It should, however, be noted that outcomes reported in an animal model are not always replicable in a human model (48).”
BackgroundNMR Metabolomics Methods for Investigating Disease
Gowda, G. A. N., & Raftery, D. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04606 · Cited by 91
Recent methods of droplet microfluidics and their applications in spheroids and organoids
Wang, Y., Liu, M., Zhang, Y., Liu, H., & Han, L. G. (2023) · Lab on a Chip · doi:10.1039/d2lc00493c · Cited by 91
Usta, O. B., McCarty, W. J., Bale, S., Hegde, M., Jindal, R., Bhushan, A., Golberg, I., & Yarmush, M. L. (2015) · TECHNOLOGY · doi:10.1142/s2339547815300012 · Cited by 85
Li, X., Zheng, M., Xu, B., Li, D., Shen, Y., Nie, Y., Ma, L., & Wu, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121213 · Cited by 90
Challenges in conducting clinical research studies in pregnant women
McKiever, M. E., Frey, H. A., & Costantine, M. M. (2020) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-020-09687-z · Cited by 88
Yu, L., Zhao, X., Cheng, M.-L., Yang, G.-Z., Bi, W., Liu, H.-J., Hu, Y., Zhu, L., Zhang, S., Xiao, Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01271-9 · Cited by 86
Bioprinting Neural Systems to Model Central Nervous System Diseases
Qiu, B., Bessler, N., Figler, K. P., Buchholz, M., Rios, A. C., Malda, J., Levato, R., & Caiazzo, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910250 · Cited by 86
Public perception of laboratory animal testing: Historical, philosophical, and ethical view
Petetta, F., & Ciccocioppo, R. (2020) · Addiction Biology · doi:10.1111/adb.12991 · Cited by 86
Talbert, D. R., Doherty, K. R., Trusk, P. B., Moran, D. M., Shell, S. A., & Bacus, S. S. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu215 · Cited by 84
Chen, X., Roberts, R. A., Tong, W., & Liu, Z. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab157 · Cited by 83
Emerging Technologies for In Vitro Inhalation Toxicology
Singh, A. V., Romeo, A. A., Scott, K., Wagener, S., Leibrock, L., Laux, P., Luch, A., Kerkar, P., Balakrishnan, S., Dakua, S. P., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100633 · Cited by 81
Health impact of childhood and adolescent soy consumption
Messina, M. J., Rogero, M. M., Fisberg, M., & Waitzberg, D. L. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux016 · Cited by 81
Toward the broad adoption of 3D tumor models in the cancer drug pipeline
Cox, M. C., Reese, L. M., Bickford, L. R., & Verbridge, S. S. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00172 · Cited by 80
Metadata
- Authors
- Shanks, N., Greek, R., & Greek, J.
- Affiliations
- Wichita State University (US)
- Corresponding author
- Greek, Ray
- Venue
- Philosophy, Ethics, and Humanities in Medicine
- Published
- 2009-01-15
- Volume
- 4
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1747-5341 (ISSN-L)
- PMC
- PMC2642860
- OpenAlex
- W2030932194
- Cited by
- 677
- References
- 79
- Citations by year
- 2026: 18 · 2025: 38 · 2024: 53 · 2023: 43 · 2022: 66 · 2021: 69 · 2020: 69 · 2019: 64 · 2018: 67 · 2017: 47 · 2016: 37 · 2015: 35 · 2014: 19 · 2013: 21 · 2012: 13
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Philosophy Ethics and Humanities in Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- WBI Studies Repository (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Philosophy of Biology and Scientific Explanation
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- animal models, predictive validity, animal-to-human extrapolation, toxicology, pathophysiology, drug response prediction, scientific terminology, epigenetics, comparative genomics, complexity theory, evolutionary biology, developmental biology, gene expression regulation
- MeSH terms
- Animals, Forecasting, Humans, Models, Animal, Animal Experimentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.